Global Nucleic Acid-based Drugs Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Page: 94

Published Date: 17 Nov 2021

Category: New Technology

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Product Tags

Description

The Nucleic Acid-based Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Nucleic Acid-based Drugs size is estimated to be USD  million in 2026 from USD  million in 2020, with a change  % between 2020 and 2021. The global Nucleic Acid-based Drugs market size is expected to grow at a CAGR of  % for the next five years.

Market segmentation
Nucleic Acid-based Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
    ASO
    mRNA
    siRNA
    miRNA
    saRNA
    Aptamer

Market segment by Application, can be divided into
    Genetic Disease
    Cancer
    Cardiovascular Diseases
    Other

Market segment by players, this report covers
    Ionis Pharmaceuticals
    Sarepta Therapeutics
    Nippon Shinyaku
    BioNTech
    Moderna Therapeutics
    CureVac
    Alnylam Pharmaceuticals
    Regulus Therapeutics
    Miragen Therapeutics
    Mina Therapeutics
    NeXstar Pharmaceuticals

Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
    South America (Brazil, Argentina, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Nucleic Acid-based Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Nucleic Acid-based Drugs, with revenue, gross margin and global market share of Nucleic Acid-based Drugs from 2019 to 2021.
Chapter 3, the Nucleic Acid-based Drugs competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Nucleic Acid-based Drugs market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Nucleic Acid-based Drugs research findings and conclusion, appendix and data source.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of Nucleic Acid-based Drugs
    1.2 Classification of Nucleic Acid-based Drugs by Type
        1.2.1 Overview: Global Nucleic Acid-based Drugs Market Size by Type: 2020 Versus 2021 Versus 2026
        1.2.2 Global Nucleic Acid-based Drugs Revenue Market Share by Type in 2020
        1.2.3 ASO
        1.2.4 mRNA
        1.2.5 siRNA
        1.2.6 miRNA
        1.2.7 saRNA
        1.2.8 Aptamer
    1.3 Global Nucleic Acid-based Drugs Market by Application
        1.3.1 Overview: Global Nucleic Acid-based Drugs Market Size by Application: 2020 Versus 2021 Versus 2026
        1.3.2 Genetic Disease
        1.3.3 Cancer
        1.3.4 Cardiovascular Diseases
        1.3.5 Other
    1.4 Global Nucleic Acid-based Drugs Market Size & Forecast
    1.5 Global Nucleic Acid-based Drugs Market Size and Forecast by Region
        1.5.1 Global Nucleic Acid-based Drugs Market Size by Region: 2016 VS 2021 VS 2026
        1.5.2 Global Nucleic Acid-based Drugs Market Size by Region, (2016-2021)
        1.5.3 North America Nucleic Acid-based Drugs Market Size and Prospect (2016-2026)
        1.5.4 Europe Nucleic Acid-based Drugs Market Size and Prospect (2016-2026)
        1.5.5 Asia-Pacific Nucleic Acid-based Drugs Market Size and Prospect (2016-2026)
        1.5.6 South America Nucleic Acid-based Drugs Market Size and Prospect (2016-2026)
        1.5.7 Middle East and Africa Nucleic Acid-based Drugs Market Size and Prospect (2016-2026)
    1.6 Market Drivers, Restraints and Trends
        1.6.1 Nucleic Acid-based Drugs Market Drivers
        1.6.2 Nucleic Acid-based Drugs Market Restraints
        1.6.3 Nucleic Acid-based Drugs Trends Analysis

2 Company Profiles
    2.1 Ionis Pharmaceuticals
        2.1.1 Ionis Pharmaceuticals Details
        2.1.2 Ionis Pharmaceuticals Major Business
        2.1.3 Ionis Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
        2.1.4 Ionis Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.1.5 Ionis Pharmaceuticals Recent Developments and Future Plans
    2.2 Sarepta Therapeutics
        2.2.1 Sarepta Therapeutics Details
        2.2.2 Sarepta Therapeutics Major Business
        2.2.3 Sarepta Therapeutics Nucleic Acid-based Drugs Product and Solutions
        2.2.4 Sarepta Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.2.5 Sarepta Therapeutics Recent Developments and Future Plans
    2.3 Nippon Shinyaku
        2.3.1 Nippon Shinyaku Details
        2.3.2 Nippon Shinyaku Major Business
        2.3.3 Nippon Shinyaku Nucleic Acid-based Drugs Product and Solutions
        2.3.4 Nippon Shinyaku Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.3.5 Nippon Shinyaku Recent Developments and Future Plans
    2.4 BioNTech
        2.4.1 BioNTech Details
        2.4.2 BioNTech Major Business
        2.4.3 BioNTech Nucleic Acid-based Drugs Product and Solutions
        2.4.4 BioNTech Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.4.5 BioNTech Recent Developments and Future Plans
    2.5 Moderna Therapeutics
        2.5.1 Moderna Therapeutics Details
        2.5.2 Moderna Therapeutics Major Business
        2.5.3 Moderna Therapeutics Nucleic Acid-based Drugs Product and Solutions
        2.5.4 Moderna Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.5.5 Moderna Therapeutics Recent Developments and Future Plans
    2.6 CureVac
        2.6.1 CureVac Details
        2.6.2 CureVac Major Business
        2.6.3 CureVac Nucleic Acid-based Drugs Product and Solutions
        2.6.4 CureVac Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.6.5 CureVac Recent Developments and Future Plans
    2.7 Alnylam Pharmaceuticals
        2.7.1 Alnylam Pharmaceuticals Details
        2.7.2 Alnylam Pharmaceuticals Major Business
        2.7.3 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
        2.7.4 Alnylam Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.7.5 Alnylam Pharmaceuticals Recent Developments and Future Plans
    2.8 Regulus Therapeutics
        2.8.1 Regulus Therapeutics Details
        2.8.2 Regulus Therapeutics Major Business
        2.8.3 Regulus Therapeutics Nucleic Acid-based Drugs Product and Solutions
        2.8.4 Regulus Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.8.5 Regulus Therapeutics Recent Developments and Future Plans
    2.9 Miragen Therapeutics
        2.9.1 Miragen Therapeutics Details
        2.9.2 Miragen Therapeutics Major Business
        2.9.3 Miragen Therapeutics Nucleic Acid-based Drugs Product and Solutions
        2.9.4 Miragen Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.9.5 Miragen Therapeutics Recent Developments and Future Plans
    2.10 Mina Therapeutics
        2.10.1 Mina Therapeutics Details
        2.10.2 Mina Therapeutics Major Business
        2.10.3 Mina Therapeutics Nucleic Acid-based Drugs Product and Solutions
        2.10.4 Mina Therapeutics Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.10.5 Mina Therapeutics Recent Developments and Future Plans
    2.11 NeXstar Pharmaceuticals
        2.11.1 NeXstar Pharmaceuticals Details
        2.11.2 NeXstar Pharmaceuticals Major Business
        2.11.3 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
        2.11.4 NeXstar Pharmaceuticals Nucleic Acid-based Drugs Revenue, Gross Margin and Market Share (2019-2021)
        2.11.5 NeXstar Pharmaceuticals Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Nucleic Acid-based Drugs Revenue and Share by Players (2019-2021)
    3.2 Market Concentration Rate
        3.2.1 Top 3 Nucleic Acid-based Drugs Players Market Share
        3.2.2 Top 10 Nucleic Acid-based Drugs Players Market Share
        3.2.3 Market Competition Trend
    3.3 Nucleic Acid-based Drugs Players Head Office, Products and Services Provided
    3.4 Mergers & Acquisitions
    3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type
    4.1 Global Nucleic Acid-based Drugs Revenue and Market Share by Type (2016-2021)
    4.2 Global Nucleic Acid-based Drugs Market Forecast by Type (2021-2026)

5 Market Size Segment by Application
    5.1 Global Nucleic Acid-based Drugs Revenue Market Share by Application (2016-2021)
    5.2 Nucleic Acid-based Drugs Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application
    6.1 North America Nucleic Acid-based Drugs Revenue by Type (2016-2026)
    6.2 North America Nucleic Acid-based Drugs Revenue by Application (2016-2026)
    6.3 North America Nucleic Acid-based Drugs Market Size by Country
        6.3.1 North America Nucleic Acid-based Drugs Revenue by Country (2016-2026)
        6.3.2 United States Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        6.3.3 Canada Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        6.3.4 Mexico Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application
    7.1 Europe Nucleic Acid-based Drugs Revenue by Type (2016-2026)
    7.2 Europe Nucleic Acid-based Drugs Revenue by Application (2016-2026)
    7.3 Europe Nucleic Acid-based Drugs Market Size by Country
        7.3.1 Europe Nucleic Acid-based Drugs Revenue by Country (2016-2026)
        7.3.2 Germany Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        7.3.3 France Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        7.3.4 United Kingdom Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        7.3.5 Russia Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        7.3.6 Italy Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application
    8.1 Asia-Pacific Nucleic Acid-based Drugs Revenue by Type (2016-2026)
    8.2 Asia-Pacific Nucleic Acid-based Drugs Revenue by Application (2016-2026)
    8.3 Asia-Pacific Nucleic Acid-based Drugs Market Size by Region
        8.3.1 Asia-Pacific Nucleic Acid-based Drugs Revenue by Region (2016-2026)
        8.3.2 China Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        8.3.3 Japan Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        8.3.4 South Korea Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        8.3.5 India Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        8.3.6 Southeast Asia Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        8.3.7 Australia Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application
    9.1 South America Nucleic Acid-based Drugs Revenue by Type (2016-2026)
    9.2 South America Nucleic Acid-based Drugs Revenue by Application (2016-2026)
    9.3 South America Nucleic Acid-based Drugs Market Size by Country
        9.3.1 South America Nucleic Acid-based Drugs Revenue by Country (2016-2026)
        9.3.2 Brazil Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        9.3.3 Argentina Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application
    10.1 Middle East & Africa Nucleic Acid-based Drugs Revenue by Type (2016-2026)
    10.2 Middle East & Africa Nucleic Acid-based Drugs Revenue by Application (2016-2026)
    10.3 Middle East & Africa Nucleic Acid-based Drugs Market Size by Country
        10.3.1 Middle East & Africa Nucleic Acid-based Drugs Revenue by Country (2016-2026)
        10.3.2 Turkey Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        10.3.3 Saudi Arabia Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)
        10.3.4 UAE Nucleic Acid-based Drugs Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix
    12.1 Methodology
    12.2 Research Process and Data Source
    12.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global Nucleic Acid-based Drugs Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
    Table 2. Global Nucleic Acid-based Drugs Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
    Table 3. Global Market Nucleic Acid-based Drugs Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
    Table 4. Global Nucleic Acid-based Drugs Revenue (USD Million) by Region (2016-2021)
    Table 5. Global Nucleic Acid-based Drugs Revenue Market Share by Region (2021-2026)
    Table 6. Ionis Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 7. Ionis Pharmaceuticals Major Business
    Table 8. Ionis Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
    Table 9. Ionis Pharmaceuticals Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 10. Sarepta Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 11. Sarepta Therapeutics Major Business
    Table 12. Sarepta Therapeutics Nucleic Acid-based Drugs Product and Solutions
    Table 13. Sarepta Therapeutics Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 14. Nippon Shinyaku Corporate Information, Head Office, and Major Competitors
    Table 15. Nippon Shinyaku Major Business
    Table 16. Nippon Shinyaku Nucleic Acid-based Drugs Product and Solutions
    Table 17. Nippon Shinyaku Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 18. BioNTech Corporate Information, Head Office, and Major Competitors
    Table 19. BioNTech Major Business
    Table 20. BioNTech Nucleic Acid-based Drugs Product and Solutions
    Table 21. BioNTech Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 22. Moderna Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 23. Moderna Therapeutics Major Business
    Table 24. Moderna Therapeutics Nucleic Acid-based Drugs Product and Solutions
    Table 25. Moderna Therapeutics Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 26. CureVac Corporate Information, Head Office, and Major Competitors
    Table 27. CureVac Major Business
    Table 28. CureVac Nucleic Acid-based Drugs Product and Solutions
    Table 29. CureVac Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 30. Alnylam Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 31. Alnylam Pharmaceuticals Major Business
    Table 32. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
    Table 33. Alnylam Pharmaceuticals Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 34. Regulus Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 35. Regulus Therapeutics Major Business
    Table 36. Regulus Therapeutics Nucleic Acid-based Drugs Product and Solutions
    Table 37. Regulus Therapeutics Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 38. Miragen Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 39. Miragen Therapeutics Major Business
    Table 40. Miragen Therapeutics Nucleic Acid-based Drugs Product and Solutions
    Table 41. Miragen Therapeutics Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 42. Mina Therapeutics Corporate Information, Head Office, and Major Competitors
    Table 43. Mina Therapeutics Major Business
    Table 44. Mina Therapeutics Nucleic Acid-based Drugs Product and Solutions
    Table 45. Mina Therapeutics Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 46. NeXstar Pharmaceuticals Corporate Information, Head Office, and Major Competitors
    Table 47. NeXstar Pharmaceuticals Major Business
    Table 48. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Product and Solutions
    Table 49. NeXstar Pharmaceuticals Nucleic Acid-based Drugs Revenue (USD Million), Gross Margin and Market Share (2019-2021)
    Table 50. Global Nucleic Acid-based Drugs Revenue (USD Million) by Players (2019-2021)
    Table 51. Global Nucleic Acid-based Drugs Revenue Share by Players (2019-2021)
    Table 52. Breakdown of Nucleic Acid-based Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
    Table 53. Nucleic Acid-based Drugs Players Head Office, Products and Services Provided
    Table 54. Nucleic Acid-based Drugs Mergers & Acquisitions in the Past Five Years
    Table 55. Nucleic Acid-based Drugs New Entrants and Expansion Plans
    Table 56. Global Nucleic Acid-based Drugs Revenue (USD Million) by Type (2016-2021)
    Table 57. Global Nucleic Acid-based Drugs Revenue Share by Type (2016-2021)
    Table 58. Global Nucleic Acid-based Drugs Revenue Forecast by Type (2021-2026)
    Table 59. Global Nucleic Acid-based Drugs Revenue by Application (2016-2021)
    Table 60. Global Nucleic Acid-based Drugs Revenue Forecast by Application (2021-2026)
    Table 61. North America Nucleic Acid-based Drugs Revenue by Type (2016-2021) & (USD Million)
    Table 62. North America Nucleic Acid-based Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 63. North America Nucleic Acid-based Drugs Revenue by Application (2016-2021) & (USD Million)
    Table 64. North America Nucleic Acid-based Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 65. North America Nucleic Acid-based Drugs Revenue by Country (2016-2021) & (USD Million)
    Table 66. North America Nucleic Acid-based Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 67. Europe Nucleic Acid-based Drugs Revenue by Type (2016-2021) & (USD Million)
    Table 68. Europe Nucleic Acid-based Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 69. Europe Nucleic Acid-based Drugs Revenue by Application (2016-2021) & (USD Million)
    Table 70. Europe Nucleic Acid-based Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 71. Europe Nucleic Acid-based Drugs Revenue by Country (2016-2021) & (USD Million)
    Table 72. Europe Nucleic Acid-based Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 73. Asia-Pacific Nucleic Acid-based Drugs Revenue by Type (2016-2021) & (USD Million)
    Table 74. Asia-Pacific Nucleic Acid-based Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 75. Asia-Pacific Nucleic Acid-based Drugs Revenue by Application (2016-2021) & (USD Million)
    Table 76. Asia-Pacific Nucleic Acid-based Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 77. Asia-Pacific Nucleic Acid-based Drugs Revenue by Region (2016-2021) & (USD Million)
    Table 78. Asia-Pacific Nucleic Acid-based Drugs Revenue by Region (2021-2026) & (USD Million)
    Table 79. South America Nucleic Acid-based Drugs Revenue by Type (2016-2021) & (USD Million)
    Table 80. South America Nucleic Acid-based Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 81. South America Nucleic Acid-based Drugs Revenue by Application (2016-2021) & (USD Million)
    Table 82. South America Nucleic Acid-based Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 83. South America Nucleic Acid-based Drugs Revenue by Country (2016-2021) & (USD Million)
    Table 84. South America Nucleic Acid-based Drugs Revenue by Country (2021-2026) & (USD Million)
    Table 85. Middle East & Africa Nucleic Acid-based Drugs Revenue by Type (2016-2021) & (USD Million)
    Table 86. Middle East & Africa Nucleic Acid-based Drugs Revenue by Type (2021-2026) & (USD Million)
    Table 87. Middle East & Africa Nucleic Acid-based Drugs Revenue by Application (2016-2021) & (USD Million)
    Table 88. Middle East & Africa Nucleic Acid-based Drugs Revenue by Application (2021-2026) & (USD Million)
    Table 89. Middle East & Africa Nucleic Acid-based Drugs Revenue by Country (2016-2021) & (USD Million)
    Table 90. Middle East & Africa Nucleic Acid-based Drugs Revenue by Country (2021-2026) & (USD Million)
List of Figures
    Figure 1. Nucleic Acid-based Drugs Picture
    Figure 2. Global Nucleic Acid-based Drugs Revenue Market Share by Type in 2020
    Figure 3. ASO
    Figure 4. mRNA
    Figure 5. siRNA
    Figure 6. miRNA
    Figure 7. saRNA
    Figure 8. Aptamer
    Figure 9. Nucleic Acid-based Drugs Revenue Market Share by Application in 2020
    Figure 10. Genetic Disease Picture
    Figure 11. Cancer Picture
    Figure 12. Cardiovascular Diseases Picture
    Figure 13. Other Picture
    Figure 14. Global Nucleic Acid-based Drugs Revenue, (USD Million): 2020 VS 2021 VS 2026
    Figure 15. Global Nucleic Acid-based Drugs Revenue and Forecast (2016-2026) & (USD Million)
    Figure 16. Global Nucleic Acid-based Drugs Revenue Market Share by Region (2016-2026)
    Figure 17. Global Nucleic Acid-based Drugs Revenue Market Share by Region in 2020
    Figure 18. North America Nucleic Acid-based Drugs Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 19. Europe Nucleic Acid-based Drugs Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 20. Asia-Pacific Nucleic Acid-based Drugs Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 21. South America Nucleic Acid-based Drugs Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 22. Middle East and Africa Nucleic Acid-based Drugs Revenue (USD Million) and Growth Rate (2016-2026)
    Figure 23. Nucleic Acid-based Drugs Market Drivers
    Figure 24. Nucleic Acid-based Drugs Market Restraints
    Figure 25. Nucleic Acid-based Drugs Market Trends
    Figure 26. Ionis Pharmaceuticals Recent Developments and Future Plans
    Figure 27. Sarepta Therapeutics Recent Developments and Future Plans
    Figure 28. Nippon Shinyaku Recent Developments and Future Plans
    Figure 29. BioNTech Recent Developments and Future Plans
    Figure 30. Moderna Therapeutics Recent Developments and Future Plans
    Figure 31. CureVac Recent Developments and Future Plans
    Figure 32. Alnylam Pharmaceuticals Recent Developments and Future Plans
    Figure 33. Regulus Therapeutics Recent Developments and Future Plans
    Figure 34. Miragen Therapeutics Recent Developments and Future Plans
    Figure 35. Mina Therapeutics Recent Developments and Future Plans
    Figure 36. NeXstar Pharmaceuticals Recent Developments and Future Plans
    Figure 37. Global Nucleic Acid-based Drugs Revenue Share by Players in 2020
    Figure 38. Nucleic Acid-based Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    Figure 39. Global Top 3 Players Nucleic Acid-based Drugs Revenue Market Share in 2020
    Figure 40. Global Top 10 Players Nucleic Acid-based Drugs Revenue Market Share in 2020
    Figure 41. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
    Figure 42. Global Nucleic Acid-based Drugs Revenue Share by Type in 2020
    Figure 43. Global Nucleic Acid-based Drugs Market Share Forecast by Type (2021-2026)
    Figure 44. Global Nucleic Acid-based Drugs Revenue Share by Application in 2020
    Figure 45. Global Nucleic Acid-based Drugs Market Share Forecast by Application (2021-2026)
    Figure 46. North America Nucleic Acid-based Drugs Sales Market Share by Type (2016-2026)
    Figure 47. North America Nucleic Acid-based Drugs Sales Market Share by Application (2016-2026)
    Figure 48. North America Nucleic Acid-based Drugs Revenue Market Share by Country (2016-2026)
    Figure 49. United States Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 50. Canada Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 51. Mexico Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 52. Europe Nucleic Acid-based Drugs Sales Market Share by Type (2016-2026)
    Figure 53. Europe Nucleic Acid-based Drugs Sales Market Share by Application (2016-2026)
    Figure 54. Europe Nucleic Acid-based Drugs Revenue Market Share by Country (2016-2026)
    Figure 55. Germany Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 56. France Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 57. United Kingdom Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 58. Russia Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 59. Italy Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 60. Asia-Pacific Nucleic Acid-based Drugs Sales Market Share by Type (2016-2026)
    Figure 61. Asia-Pacific Nucleic Acid-based Drugs Sales Market Share by Application (2016-2026)
    Figure 62. Asia-Pacific Nucleic Acid-based Drugs Revenue Market Share by Region (2016-2026)
    Figure 63. China Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 64. Japan Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 65. South Korea Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 66. India Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 67. Southeast Asia Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 68. Australia Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 69. South America Nucleic Acid-based Drugs Sales Market Share by Type (2016-2026)
    Figure 70. South America Nucleic Acid-based Drugs Sales Market Share by Application (2016-2026)
    Figure 71. South America Nucleic Acid-based Drugs Revenue Market Share by Country (2016-2026)
    Figure 72. Brazil Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 73. Argentina Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 74. Middle East and Africa Nucleic Acid-based Drugs Sales Market Share by Type (2016-2026)
    Figure 75. Middle East and Africa Nucleic Acid-based Drugs Sales Market Share by Application (2016-2026)
    Figure 76. Middle East and Africa Nucleic Acid-based Drugs Revenue Market Share by Country (2016-2026)
    Figure 77. Turkey Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 78. Saudi Arabia Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 79. UAE Nucleic Acid-based Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
    Figure 80. Methodology
    Figure 81. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Ionis Pharmaceuticals
Sarepta Therapeutics
Nippon Shinyaku
BioNTech
Moderna Therapeutics
CureVac
Alnylam Pharmaceuticals
Regulus Therapeutics
Miragen Therapeutics
Mina Therapeutics
NeXstar Pharmaceuticals

Product Tags

nucleic acid based drugs

Nucleic Acid-based Drugs

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>